Report Detail
Global Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3466890 |
- 28 June, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Other
Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a rapid pace.
Non-small cell lung cancer is the most common type of lung cancer that causes mortality and morbidity in both developed and developing countries. The approval of late-stage pipeline products like onartuzumab and necitumumab is expected to foster growth in this market, resulting in its steady market growth.
In 2018, the global Non-Small Cell Lung Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Novartis
AstraZeneca
Roche
Bristol-Myers Squibb
Pfizer
Eli Lilly
Sanofi
Market segment by Type, the product can be split into
Biologics
Small molecules
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Non-Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-Small Cell Lung Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Biologics
- 1.4.3 Small molecules
- 1.5 Market by Application
- 1.5.1 Global Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Non-Small Cell Lung Cancer Therapeutics Market Size
- 2.2 Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions
- 2.2.1 Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Non-Small Cell Lung Cancer Therapeutics Market Size by Manufacturers
- 3.1.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Non-Small Cell Lung Cancer Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Non-Small Cell Lung Cancer Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 5.2 Non-Small Cell Lung Cancer Therapeutics Key Players in United States
- 5.3 United States Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 5.4 United States Non-Small Cell Lung Cancer Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 6.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Europe
- 6.3 Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 6.4 Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Application
7 China
- 7.1 China Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 7.2 Non-Small Cell Lung Cancer Therapeutics Key Players in China
- 7.3 China Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 7.4 China Non-Small Cell Lung Cancer Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 8.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Japan
- 8.3 Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 8.4 Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 9.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 9.4 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Application
10 India
- 10.1 India Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 10.2 Non-Small Cell Lung Cancer Therapeutics Key Players in India
- 10.3 India Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 10.4 India Non-Small Cell Lung Cancer Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
- 11.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Central & South America
- 11.3 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Type
- 11.4 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 GlaxoSmithKline
- 12.1.1 GlaxoSmithKline Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.1.4 GlaxoSmithKline Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.1.5 GlaxoSmithKline Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.2.4 Novartis Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.2.5 Novartis Recent Development
- 12.3 AstraZeneca
- 12.3.1 AstraZeneca Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.3.4 AstraZeneca Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.3.5 AstraZeneca Recent Development
- 12.4 Roche
- 12.4.1 Roche Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.4.4 Roche Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.4.5 Roche Recent Development
- 12.5 Bristol-Myers Squibb
- 12.5.1 Bristol-Myers Squibb Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.5.4 Bristol-Myers Squibb Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.5.5 Bristol-Myers Squibb Recent Development
- 12.6 Pfizer
- 12.6.1 Pfizer Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.6.4 Pfizer Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.6.5 Pfizer Recent Development
- 12.7 Eli Lilly
- 12.7.1 Eli Lilly Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.7.4 Eli Lilly Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.7.5 Eli Lilly Recent Development
- 12.8 Sanofi
- 12.8.1 Sanofi Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Non-Small Cell Lung Cancer Therapeutics Introduction
- 12.8.4 Sanofi Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
- 12.8.5 Sanofi Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Non-Small Cell Lung Cancer Therapeutics. Industry analysis & Market Report on Non-Small Cell Lung Cancer Therapeutics is a syndicated market report, published as Global Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Non-Small Cell Lung Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
